Investor FAQs

Show all
Eledon is headquartered at 19900 MacArthur Blvd., Suite 550, Irvine, CA 92612. The main phone number is (949) 238-8090.
The company was originally incorporated in the state of Delaware under the name Tokai Pharmaceuticals, Inc. in 2004, changed its name to Novus Therapeutics, Inc. in 2017, and renamed in 2021 to Eledon Pharmaceuticals, Inc.
Eledon is traded on the NASDAQ Capital Market under the ticker symbol ELDN and its CUSIP number is 28617K 101.
Shares of ELDN can be purchased through a stockbroker of your choice.
December 31st
Continental Stock Transfer & Trust
Phone: (212) 845-3224
17 Battery Place, 8th Floor
New York, NY 10004
Press release archives can be accessed in the Press Releases section of the website.
SEC filings can be accessed in the SEC Filings section of the site or
You may submit your questions to Investor Relations by contacting